LUNG TRANSPLANT RECIPIENT
Clinical trials for LUNG TRANSPLANT RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT RECIPIENT trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Two-Drug punch knock out CMV faster in lung transplants?
Disease control Recruiting nowThis study tests whether adding letermovir to standard antiviral treatment helps clear cytomegalovirus (CMV) infection faster in people who have received a lung transplant. About 40 participants will receive either letermovir or a placebo alongside their usual medication for 21 d…
Matched conditions: LUNG TRANSPLANT RECIPIENT
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could UV light make hepatitis b donor lungs safe for transplant?
Disease control Recruiting nowThis study tests whether lungs from donors with hepatitis B can be safely given to people who do not have hepatitis B. The donated lungs are treated with UV light during a special preservation process, and recipients receive antiviral drugs and antibodies to prevent infection. Tw…
Matched conditions: LUNG TRANSPLANT RECIPIENT
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC